Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
58106 Results Found
Supreme Court Dismisses Third Major Challenge to Affordable Care Act
The United States Supreme Court this morning rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did not have “standing,” or the legal right to challenge the portions of the ACA they alleged were unconstitutional.
STATEMENT ON SUPREME COURT DECISION ON THE AFFORDABLE CARE ACT
Statement on Supreme Court decision on the Affordable Care Act from AHA President and CEO Rick Pollack.
CMS to take flexible approach to survey process if hospital experiences COVID-19 surge
As requested by the AHA, the Centers for Medicare & Medicaid Services said it will continue to remain flexible in its approach to surveys if a hospital experiences a COVID-19 surge.
AHA podcast: Local businesses’ role in increasing equitable health outcomes
On this AHA Advancing Health podcast, Leon Caldwell, AHA’s senior director of health equity strategies and innovation, talks with Keith Ellison, program director of the Urban League of Philadelphia Entrepreneurship Center, about how the COVID-19 pandemic highlighted the pivotal role local businesses play in advancing equitable health outcomes, as well as the challenges and opportunities they face during the road to recovery.
NIH study: SARS-CoV-2 arrived in U.S. earlier than reported
A National Institutes of Health-led review of more than 24,000 stored blood samples suggests that the coronavirus that causes COVID-19 was present in the U.S. as far back as December 2019.
FDA authorizes additional drug substance batch for use in J&J vaccine
The Food and Drug Administration authorized for emergency use one more batch of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.
ASPR pauses distribution of bamlanivimab and etesevimab in R.I. due to variant
Rhode Island health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response announced.
Maturity Framework: Data-driven Health Care Organizations | Market Insights | Center
Each organization can use this maturity framework to assess its current capabilities to determine where they are as a data-driven organization and how this impacts their digital transformation.
Discussion Guide: Developing Data-driven Health Care Organizations | Market Insights | Center
This discussion guide facilitates conversations, ideas and actions that hospital and health system leaders should consider in their quest to become data-driven organizations that use data for health care innovation. As hospital and health care systems continue to build and refine their data strategies, leaders need to answer these 18 questions to take stock of current data capabilities and gaps, and ensure their data strategy is aligned with their organizational strategy.